Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 5
222
Views
6
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Metabolism, excretion, and pharmacokinetics of [14C]mirogabalin, a novel α2δ ligand, in healthy volunteers following oral administration

, , , , , , & show all
Pages 549-563 | Received 09 Nov 2020, Accepted 18 Jan 2021, Published online: 03 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Naotoshi Yamamura, Tomoki Imaoka, Misa Hoshi, Makiko Yamada & Ken-ichi Itokawa. (2023) Renal tubular transporter-mediated interactions between mirogabalin and cimetidine in rats. Xenobiotica 53:2, pages 114-122.
Read now
Naotoshi Yamamura, Tsuyoshi Mikkaichi, Ken-ichi Itokawa, Misa Hoshi, Katja Damme, Stefanie Geigner & Christine Baumhauer. (2022) Mirogabalin, a novel α2δ ligand, is not a substrate of LAT1, but of PEPT1, PEPT2, OAT1, OAT3, OCT2, MATE1 and MATE2-K. Xenobiotica 52:9-11, pages 997-1009.
Read now
Naotoshi Yamamura, Minoru Uchiyama, Makoto Takahashi, Tomoyo Honda & Yumi Nishiya. (2022) Pharmacokinetics and metabolism of mirogabalin, a novel α2δ ligand, in rats and monkeys. Xenobiotica 52:1, pages 54-64.
Read now

Articles from other publishers (3)

Kaoru Toyama, Takashi Eto, Kanae Suzuki, Sayaka Shinohara, Satoshi Yoshiba, Kazutaka Yoshihara & Hitoshi Ishizuka. (2023) Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants. Clinical Pharmacology in Drug Development.
Crossref
Hui Tang, Jing Lu, Yazhuo Duan & Dejun Li. (2023) The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids. Mediators of Inflammation 2023, pages 1-13.
Crossref
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development 137 174 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.